Apyx Medical Corp (APYX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 52,844 | 48,102 | 52,349 | 44,510 | 48,517 |
| Cost of Goods | 19,800 | 18,742 | 18,590 | 15,379 | 14,916 |
| Gross Profit | 33,044 | 29,360 | 33,759 | 29,131 | 33,601 |
| Operating Expenses | 40,290 | 48,947 | 51,608 | 53,072 | 48,965 |
| Operating Income | -6,446 | -18,845 | -17,259 | -23,562 | -14,448 |
| Interest Expense | 5,589 | 5,907 | 2,478 | 15 | 10 |
| Other Income | 1,200 | 1,445 | -1,545 | 666 | -362 |
| Pre-tax Income | -10,835 | -23,307 | -21,282 | -22,911 | -14,820 |
| Income Tax | 270 | 252 | -2,432 | 367 | 380 |
| Net Income Continuous | -11,105 | -23,559 | -18,850 | -23,278 | -15,200 |
| Minority Interests | 106 | -96 | -137 | -94 | -28 |
| Net Income | $-11,211 | $-23,463 | $-18,713 | $-23,184 | $-15,172 |
| EPS Basic Total Ops | -0.27 | -0.66 | -0.54 | -0.67 | -0.44 |
| EPS Basic Continuous Ops | -0.27 | -0.66 | -0.54 | -0.67 | -0.44 |
| EPS Diluted Total Ops | -0.27 | -0.66 | -0.54 | -0.67 | -0.44 |
| EPS Diluted Continuous Ops | -0.27 | -0.66 | -0.54 | -0.67 | -0.44 |
| EPS Diluted Before Non-Recurring Items | -0.27 | -0.66 | -0.53 | -0.67 | -0.44 |
| EBITDA(a) | $-5,791 | $-18,246 | $-16,567 | $-22,672 | $-13,545 |